Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rosiglitazone inhibits migration, proliferation, and phenotypic differentiation in cultured human lung fibroblasts.

Experimental lung research - 1 Mar 2010

Lin Qing, Fang Li-Ping, Zhou Wei-Wei, Liu Xin-Min

Abstract excerpt

Recent studies have indicated that peroxisome proliferator-activated receptor gamma (PPARgamma) is capable of modulating inflammation, which prompted us to investigate the potential of PPARgamma ligands as lung protective agents in pulmonary fibrosis. The present study was undertaken to investiga...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Becaplermin
Share to Cell Transdifferentiation
Share to Platelet-Derived Growth Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins c-sis

Share to Pulmonary Fibrosis

Share to Rosiglitazone

Share to Thiazolidinediones

Source

Identifiers

PMID: 20205597
DOI: 10.3109/01902140903214659

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20205597-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rosiglitazone inhibits migration, proliferation, and phenotypic differentiation in cultured human lung fibroblasts.PMID 20205597Read ↗

PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.Semantic proximity Read ↗

PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.Semantic proximity Read ↗

PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.Semantic proximity Read ↗

Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts.Semantic proximity Read ↗

Rosiglitazone ameliorates senescence-like phenotypes in a cellular photoaging model.Semantic proximity Read ↗

Dynamic regulation of platelet-derived growth factor receptor α expression in alveolar fibroblasts during realveolarization.Semantic proximity Read ↗

Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).Semantic proximity Read ↗

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.Semantic proximity Read ↗

Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-β are prevented by PPAR-γ agonists.Semantic proximity Read ↗

Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.Semantic proximity Read ↗

The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration.Semantic proximity Read ↗

New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.